SGMO Similar Chart Price Prediction
The price of SGMO is predicted to go up -17.58%, based on the high correlation periods with IPGP. The similarity of these two price pattern on the periods is 99.14%.
SGMO
IPGP
Down: -17.58%Similarity: 99.14%
SGMO Revenue Forecast
SGMO EPS Forecast
SGMO FAQs
What is bull’s view on SGMO?
What is bear's view on SGMO?
What is SGMO revenue forecast for next quarter？
SGMO Analyst's Forecast
Nicole Germino
Truist Securities
Strong Buy
2025-01-23
Price Target
$7 → $5
Upside
+320.17%
Truist analyst Nicole Germino lowered the firm's price target on Sangamo to $5 from $7 and keeps a Buy rating on the shares. The firm is updating its model to reflect the return of a BLA-ready Phase 3 asset with competitive data in Hem A and pending more clarity on the longer-term cash position from a potentially near-term announcement of a partner for Phase 3 Fabry disease asset and additional capsid partnerships, the analyst tells investors in a research note. Truist adds that the longer-term cash runway for Sangamo hinges on a partner for Fabry, which may come with a meaningful upfront and royalties payments, removing the cash overhang.
Maury Raycroft
Jefferies
Strong Buy
2024-12-31
Price Target
$7 → $3
Upside
+194.12%
Jim Birchenough
Wells Fargo
Hold
2024-12-31
Price Target
$3 → $2
Upside
+96.08%
